Each program will feature Crozer-Keystone Health System physicians, who will speak about the latest advances in cancer diagnosis and treatment. Local survivors will also attend and offer inspiring words about surviving cancer. Both events will feature music, refreshments and the passing of a light in remembrance of those who have lost their battle with cancer.
Anyone who has been diagnosed with cancer, along with his or her family members, is invited to attend this special celebration. For more information or to RSVP for Cancer Survivors Day, call 1-800-CK-HEALTH (1-800-254-3258) and indicate which celebration you would like to attend. Cancer Survivors Day will be held rain or shine.
National Cancer Survivors Day is an annual, nationwide celebration of life held in more than 650 communities throughout North America. Participants from coast to coast unite in this symbolic event to honor the 10 million Americans who are surviving a cancer diagnosis and who demonstrate that cancer survivors are active and productive members of society. For the fifth year, Crozer’s event will be generously sponsored by AstraZeneca.
Crozer-Chester Medical Center and Delaware County Memorial Hospital are part of the Fox Chase Crozer-Keystone Cancer Partnership, a clinical and research partnership between Crozer-Keystone and Fox Chase Cancer Center, a nationally acclaimed institution devoted solely to cancer care. For more information about the partnership or the cancer services offered at four Crozer-Keystone hospitals, visit http://ckcancer.crozer.org.
About AstraZeneca
AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the world's leading pharmaceutical companies with healthcare sales of $26.47 billion and leading positions in sales of gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infection products. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index.
In the United States, AstraZeneca is a $12.44 billion healthcare business with more than 12,000 employees. For nearly three decades, AstraZeneca has offered drug assistance programs side by side with its medicines, and over the past five years, has provided over $3 billion in savings to more than 1 million patients throughout the US and Puerto Rico. AstraZeneca has been named one of the “100 Best Companies for Working Mothers” by Working Mother magazine and is the only large pharmaceutical company named to FORTUNE magazine’s 2007 list of “100 Best Companies to Work For.” In 2006, for the fifth consecutive year, Science magazine named AstraZeneca a “Top Employer” on its ranking of the world’s most respected biopharmaceutical employers.
For more information about AstraZeneca, please visit: www.astrazeneca-us.com